Search Results

Chronic Respiratory Disease Drug Development Pipeline Review 2018 Featuring AstraZeneca, GlaxoSmithKline and Galapagos

• Source: M2PressWIRE. 12/17/2018.

Record details

Lilly's mirikizumab is first and only IL23p19 antagonist to report long-term, multi-year, sustained efficacy and safety data for both ulcerative colitis and Crohn's disease

• Authors : PR Newswire

Subjects: Indiana

• Source: PR Newswire US. 10/28/2024.

Record details

Women%s Health Cluster Drug Development Pipeline Review, 2017

• Authors : PR Newswire

Subjects: England

• Source: PR Newswire US. 06/08/2017.

Record details

Heptares Scientists Solve Structure of CCR9 Chemokine Receptor Offering Unique Opportunity to Apply Structure-Based Design Across Chemokine Receptor Family

• Authors : PR Newswire

Subjects: United States of America; United Kingdom

• Source: PR Newswire US. 12/08/2016.

Record details

Prescient Therapeutics Ltd Meeting on the Mesa - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 10/21/2022.

Record details

Nykode Therapeutics ASA at Jefferies London Healthcare Conference - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 11/17/2022.

Record details

ChemoCentryx Inc at BioCentury NewsMakers in the Biotech Industry Conference - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 09/27/2013.

Record details

Prescient Therapeutics Ltd Investor Presentation - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 09/26/2022.

Record details

Ikena Oncology Inc at Morgan Stanley Global Healthcare Conference - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 09/14/2022.

Record details

Prescient Therapeutics Ltd Investor Briefing - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 06/09/2022.

Record details